LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 36.00 | 771.67 | 3298 | 3884 | 0.8490 | 0.8644 | MN20160304_L01 | F04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 36.00 | 771.67 | 3696 | 3884 | 0.9514 | 0.9577 | MN20160304_L01 | F13 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 38.22 | 771.67 | 3689 | 4299 | 0.8580 | 0.8801 | MN20160304_L01 | F04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 38.22 | 771.67 | 4133 | 4299 | 0.9613 | 0.9684 | MN20160304_L01 | F13 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 40.44 | 771.67 | 4091 | 4738 | 0.8634 | 0.8909 | MN20160304_L01 | F04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 40.44 | 771.67 | 4560 | 4738 | 0.9624 | 0.9709 | MN20160304_L01 | F13 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 42.67 | 771.67 | 4523 | 5155 | 0.8773 | 0.9067 | MN20160304_L01 | F04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 42.67 | 771.67 | 4988 | 5155 | 0.9675 | 0.9760 | MN20160304_L01 | F13 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 44.89 | 771.67 | 4834 | 5541 | 0.8723 | 0.9062 | MN20160304_L01 | F04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 44.89 | 771.67 | 5304 | 5541 | 0.9571 | 0.9694 | MN20160304_L01 | F13 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 47.11 | 771.67 | 5197 | 5941 | 0.8747 | 0.9111 | MN20160304_L01 | F04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 47.11 | 771.67 | 5717 | 5941 | 0.9622 | 0.9740 | MN20160304_L01 | F13 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 49.33 | 771.67 | 5440 | 6392 | 0.8510 | 0.8970 | MN20160304_L01 | F04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 49.33 | 771.67 | 6176 | 6392 | 0.9661 | 0.9775 | MN20160304_L01 | F13 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 51.55 | 771.67 | 5914 | 6829 | 0.8659 | 0.9105 | MN20160304_L01 | F04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 51.55 | 771.67 | 6750 | 6829 | 0.9883 | 0.9926 | MN20160304_L01 | F13 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 53.77 | 771.67 | 6252 | 7256 | 0.8616 | 0.9099 | MN20160304_L01 | F04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 53.77 | 771.67 | 7348 | 7256 | 1.0126 | 1.0078 | MN20160304_L01 | F13 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 55.99 | 771.67 | 6655 | 7690 | 0.8654 | 0.9147 | MN20160304_L01 | F04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 55.99 | 771.67 | 7774 | 7690 | 1.0109 | 1.0066 | MN20160304_L01 | F13 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 58.21 | 771.67 | 7074 | 8085 | 0.8749 | 0.9227 | MN20160304_L01 | F04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 58.21 | 771.67 | 8305 | 8085 | 1.0271 | 1.0159 | MN20160304_L01 | F13 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 60.44 | 771.67 | 7424 | 8530 | 0.8703 | 0.9214 | MN20160304_L01 | F04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 60.44 | 771.67 | 8832 | 8530 | 1.0353 | 1.0201 | MN20160304_L01 | F13 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 62.66 | 771.67 | 7745 | 8978 | 0.8626 | 0.9182 | MN20160304_L01 | F04 |